Total Funding
41
22
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
88951
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.
Laurent LEVY: Co-Founder & President- Laurent LEVY: Co-founder, President France & Chief Operating Officer
About the Company
PDC*line Pharma is a clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells (PDC*line) loaded with cancer antigens. It originated from a flagship R&D program of the blood bank, where PDC*line, a proprietary plasmacytoid dendritic cell line
(PDC), was developed from a patient with a PDC leukemia.
